Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer
- Conditions
- Lung CancersRadiation Treatment for Tumors
- First Posted Date
- 2025-01-15
- Last Posted Date
- 2025-06-17
- Target Recruit Count
- 84
- Registration Number
- NCT06775678
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
- Conditions
- Primary Liver Cancer
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Target Recruit Count
- 130
- Registration Number
- NCT06766643
- Locations
- 🇨🇳
Department of Hepatobiliary Oncology and Radiation Oncology,Tianjin Medical University Cancer Institute & Hospital,Key Laboratory of Cancer Prevention and Therapy,National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin, China
A Clinical Study of CHT102 in MSLN-Positive Advanced Pancreatic Cancer
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-04-10
- Target Recruit Count
- 21
- Registration Number
- NCT06760364
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China
A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors
- First Posted Date
- 2024-12-12
- Last Posted Date
- 2024-12-12
- Target Recruit Count
- 36
- Registration Number
- NCT06730659
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors
- Conditions
- Cervical Cancers
- Interventions
- First Posted Date
- 2024-12-11
- Last Posted Date
- 2024-12-11
- Target Recruit Count
- 134
- Registration Number
- NCT06727617
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
Toripalimab Combined With Gemcitabine and Cisplatin (GemCis) as Preoperative Neoadjuvant Therapy for Resectable Intrahepatic Cholangiocarcinoma
- Conditions
- Intrahepatic Cholangiocarcinoma (Icc)
- Interventions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Target Recruit Count
- 70
- Registration Number
- NCT06721286
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer
- Conditions
- Gallbladder CancerHilar CholangiocarcinomaDistal Cholangiocarcinoma
- Interventions
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2024-12-05
- Target Recruit Count
- 110
- Registration Number
- NCT06717464
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
A Clinical Study of CHT102 in Mesothelin Positive Advanced Solid Tumors
- Conditions
- Mesothelin Positive Tumors
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 24
- Registration Number
- NCT06717022
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute & Hospital, Tianjin, Tianjin, China
A Study of 3D Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors.
- Conditions
- Kidney Neoplasms / SurgeryRobotic Surgical ProceduresImaging, Three-Dimensional / MethodsNephrectomy / Methods
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 350
- Registration Number
- NCT06717009
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
Study of Tislelizumab and Platinum-based Chemotherapy Combination With H1 Receptor Antagonist（Diphenhydramine）in Advanced and Metastatic Non-Small Cell Lung Cancer
- Conditions
- Advanced and Metastatic NSCLC
- Interventions
- First Posted Date
- 2024-11-26
- Last Posted Date
- 2024-12-16
- Target Recruit Count
- 430
- Registration Number
- NCT06704620
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, China